2-Chlorobenzimidazole → N-(Benzimidazol-2-yl)-4,4'-dichlorobenzhydrylamine
반응식
Cl[C:2]1[NH:3][C:4]2[CH:10]=[CH:9][CH:8]=[CH:7][C:5]=2[N:6]=1.[Cl:11][C:12]1[CH:26]=[CH:25][C:15]([CH:16]([NH2:24])[C:17]2[CH:22]=[CH:21][C:20]([Cl:23])=[CH:19][CH:18]=2)=[CH:14][CH:13]=1>>[N:6]1[C:5]2[CH:7]=[CH:8][CH:9]=[CH:10][C:4]=2[NH:3][C:2]=1[NH:24][CH:16]([C:15]1[CH:25]=[CH:26][C:12]([Cl:11])=[CH:13][CH:14]=1)[C:17]1[CH:18]=[CH:19][C:20]([Cl:23])=[CH:21][CH:22]=1참가 물질
3
실험 절차
The title compound was prepared from 2-chlorobenzimidazole and 4,4′-dichlorobenzhydrylamine (prepared by Procedure B from 4,4′-dichlorobenzophenone) by Procedure A. The product was isolated by preparative LCMS to give the title compound as the free base (white solid, mp 176-180° C.). MS(ES+) m/z 368 ([M+1]+, 100). 1NMR (DMSO-d6) δ6.19 (d, 1H), 6.82-6.90 (m, 2H), 7.10-7.16 (m, 2H), 7.40 (s, 8H), 7.69 (d, 1H), 10.6 (s, 1H).
후처리
- customThe product was isolated by preparative LCMS